SEC Form 4 · accession 0001209191-19-016048
Fulgent Genetics, Inc. · FLGT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Kim
Officer — CFO and Treasurer
Period of report
Feb 27, 2019
Accepted (ET)
Mar 4, 2019 · 8:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674930
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2019 | A | 20,000 | $0.00 | A | 401,180 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects an award of restricted stock units relating to 20,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after March 1, 2019, and 1/16th of the remaining shares vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Kim's continued service for Issuer on each vesting date.